OpenURL Connection Search

Select item for more details and to access through your institution.

The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states.
Published in:
Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-023-05570-9
By:
- Greinacher, Anja;
- Kuehl, Rea;
- Mai, Elias K.;
- Goldschmidt, Hartmut;
- Wiskemann, Joachim;
- Fleischer, Anna;
- Rasche, Leo;
- Dapunt, Ulrike;
- Maatouk, Imad
Publication type:
Article
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
Published in:
2016
By:
- Mai, Elias;
- Hielscher, Thomas;
- Kloth, Jost;
- Merz, Maximilian;
- Shah, Sofia;
- Hillengass, Michaela;
- Wagner, Barbara;
- Hose, Dirk;
- Raab, M.S.;
- Jauch, Anna;
- Delorme, Stefan;
- Goldschmidt, Hartmut;
- Weber, Marc-André;
- Hillengass, Jens;
- Mai, Elias K;
- Kloth, Jost K
Publication type:
journal article
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01159-8
By:
- Werly, Annika;
- Hampel, Mareike;
- Hielscher, Thomas;
- Zuern, Kosima;
- Schmidt, Sophia K.;
- Visram, Alissa;
- Raab, Marc S.;
- Mueller-Tidow, Carsten;
- Goldschmidt, Hartmut;
- Mai, Elias K.
Publication type:
Article
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01126-3
By:
- Zuern, Kosima;
- Hielscher, Thomas;
- Werly, Annika;
- Breitkreutz, Iris;
- Sauer, Sandra;
- Raab, Marc S.;
- Müller-Tidow, Carsten;
- Goldschmidt, Hartmut;
- Mai, Elias K.
Publication type:
Article
Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation.
Published in:
British Journal of Haematology, 2022, v. 196, n. 1, p. 244, doi. 10.1111/bjh.17779
By:
- Mai, Elias K.;
- Schmitt, Thomas;
- Radujkovic, Aleksandar;
- König, Laila;
- Goldschmidt, Hartmut;
- Ho, Anthony D.;
- Luft, Thomas;
- Müller‐Tidow, Carsten;
- Dreger, Peter;
- Hegenbart, Ute;
- Schönland, Stefan O.
Publication type:
Article
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG- HD2 trial.
Published in:
British Journal of Haematology, 2016, v. 173, n. 5, p. 731, doi. 10.1111/bjh.13994
By:
- Mai, Elias K.;
- Benner, Axel;
- Bertsch, Uta;
- Brossart, Peter;
- Hänel, Annette;
- Kunzmann, Volker;
- Naumann, Ralph;
- Neben, Kai;
- Egerer, Gerlinde;
- Ho, Anthony D.;
- Hillengass, Jens;
- Raab, Marc S.;
- Neubauer, Andreas;
- Peyn, Astrid;
- Ko, Yon‐Dschun;
- Peter, Norma;
- Scheid, Christof;
- Goldschmidt, Hartmut
Publication type:
Article
Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.
Published in:
Scientific Reports, 2016, p. 22084, doi. 10.1038/srep22084
By:
- Chen, Tianhui;
- Fallah, Mahdi;
- Brenner, Hermann;
- Jansen, Lina;
- Mai, Elias K.;
- Castro, Felipe A.;
- Katalinic, Alexander;
- Emrich, Katharina;
- Holleczek, Bernd;
- Geiss, Karla;
- Eberle, Andrea;
- Sundquist, Kristina;
- Hemminki, Kari
Publication type:
Article
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
Published in:
2016
By:
- Baertsch, Marc-Andrea;
- Schlenzka, Jana;
- Mai, Elias K.;
- Merz, Maximilian;
- Hillengaß, Jens;
- Raab, Marc S.;
- Hose, Dirk;
- Wuchter, Patrick;
- Ho, Anthony D.;
- Jauch, Anna;
- Hielscher, Thomas;
- Kunz, Christina;
- Luntz, Steffen;
- Klein, Stefan;
- Schmidt-Wolf, Ingo G. H.;
- Goerner, Martin;
- Schmidt-Hieber, Martin;
- Reimer, Peter;
- Graeven, Ullrich;
- Fenk, Roland
Publication type:
journal article
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384).
Published in:
Cancers, 2023, v. 15, n. 21, p. 5157, doi. 10.3390/cancers15215157
By:
- Boquoi, Amelie;
- Giagounidis, Aristoteles;
- Goldschmidt, Hartmut;
- Heinsch, Michael;
- Rummel, Mathias J.;
- Kröger, Nicolaus;
- Mai, Elias K.;
- Strapatsas, Judith;
- Haas, Rainer;
- Kobbe, Guido
Publication type:
Article
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Published in:
Cancers, 2021, v. 13, n. 19, p. 4856, doi. 10.3390/cancers13194856
By:
- Klein, Eva-Maria;
- Tichy, Diana;
- Salwender, Hans J.;
- Mai, Elias K.;
- Duerig, Jan;
- Weisel, Katja C.;
- Benner, Axel;
- Bertsch, Uta;
- Akhavanpoor, Mabast;
- Besemer, Britta;
- Munder, Markus;
- Lindemann, Hans-Walter;
- Hose, Dirk;
- Seckinger, Anja;
- Luntz, Steffen;
- Jauch, Anna;
- Elmaagacli, Ahmet;
- Fuhrmann, Stephan;
- Brossart, Peter;
- Goerner, Martin
Publication type:
Article
Potential therapeutic targets in plasma cell disorders: A flow cytometry study.
Published in:
Cytometry. Part B, 2017, v. 92, n. 2, p. 145, doi. 10.1002/cyto.b.21351
By:
- Lisenko, Katharina;
- Schönland, Stefan;
- Hegenbart, Ute;
- Wallenwein, Katrin;
- Braun, Ute;
- Mai, Elias K.;
- Hillengass, Jens;
- Goldschmidt, Hartmut;
- Jauch, Anna;
- Ho, Anthony D.;
- Raab, Marc;
- Hundemer, Michael
Publication type:
Article
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11507-9
By:
- Kauer, Joseph;
- Freundt, Emma P.;
- Schmitt, Anita;
- Weinhold, Niels;
- Mai, Elias K.;
- Müller-Tidow, Carsten;
- Goldschmidt, Hartmut;
- Raab, Marc S.;
- Kriegsmann, Katharina;
- Sauer, Sandra
Publication type:
Article
Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
Published in:
FEBS Journal, 2023, v. 290, n. 17, p. 4256, doi. 10.1111/febs.16805
By:
- Berghaus, Natalie;
- Schreiner, Sarah;
- Poos, Alexandra M.;
- Raab, Marc S.;
- Goldschmidt, Hartmut;
- Mai, Elias K.;
- Salwender, Hans‐Jürgen;
- Bernhard, Helga;
- Thurner, Lorenz;
- Müller‐Tidow, Carsten;
- Weinhold, Niels;
- Hegenbart, Ute;
- Schönland, Stefan O.;
- Huhn, Stefanie
Publication type:
Article
Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e208, doi. 10.1016/j.clml.2019.09.346
By:
- Haas, Eva-Maria;
- Salwender, Hans J.;
- Mai, Elias K.;
- Dürig, Jan;
- Weisel, Katja;
- Tichy, Diana;
- Benner, Axel;
- Kunz, Christina;
- Hielscher, Thomas;
- Bertsch, Uta;
- Besemer, Britta;
- Merz, Maximilian;
- Munder, Markus;
- Lindemann, Hans-Walter;
- Hügle-Dörr, Barbara;
- Giessen, Nicola;
- Hose, Dirk;
- Seckinger, Anja;
- Huhn, Stefanie;
- Luntz, Steffen
Publication type:
Article
Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e43, doi. 10.1016/j.clml.2019.09.065
By:
- Mai, Elias K.;
- Baertsch, Marc-A.;
- Hielscher, Thomas;
- Bertsch, Uta;
- Schlenzka, Jana;
- Salwender, Hans J.;
- Munder, Markus;
- Fuhrmann, Stephan;
- Duehrsen, Ulrich;
- Brossart, Peter;
- Neben, Kai;
- Raab, Marc S.;
- Jauch, Anna;
- Seckinger, Anja;
- Hose, Dirk;
- Luntz, Steffen;
- Sonneveld, Pieter;
- Lokhorst, Henk;
- Martin, Hans;
- Lindemann, Hans-Walter
Publication type:
Article
Response After Induction Therapy in Transplant-eligible Newly-diagnosed Myeloma - a Pooled Analysis from Three Subsequent Multicenter Phase III Trials.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e76, doi. 10.1016/j.clml.2017.03.137
By:
- Mai, Elias K.;
- Hielscher, Thomas;
- Bertsch, Uta;
- Schlenzka, Jana;
- Salwender, Hans J.;
- Munder, Markus
Publication type:
Article
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00772-9
By:
- Mai, Elias K.;
- Huhn, Stefanie;
- Miah, Kaya;
- Poos, Alexandra M.;
- Scheid, Christof;
- Weisel, Katja C.;
- Bertsch, Uta;
- Munder, Markus;
- Berlanga, Oscar;
- Hose, Dirk;
- Seckinger, Anja;
- Jauch, Anna;
- Blau, Igor W.;
- Hänel, Mathias;
- Salwender, Hans J.;
- Benner, Axel;
- Raab, Marc S.;
- Goldschmidt, Hartmut;
- Weinhold, Niels
Publication type:
Article
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00390-3
By:
- Baertsch, Marc-Andrea;
- Mai, Elias K.;
- Hielscher, Thomas;
- Bertsch, Uta;
- Salwender, Hans J.;
- Munder, Markus;
- Fuhrmann, Stephan;
- Dührsen, Ulrich;
- Brossart, Peter;
- Neben, Kai;
- Schlenzka, Jana;
- Kunz, Christina;
- Raab, Marc S.;
- Hillengaß, Jens;
- Jauch, Anna;
- Seckinger, Anja;
- Hose, Dirk;
- Luntz, Steffen;
- Sonneveld, Pieter;
- Lokhorst, Henk
Publication type:
Article
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma.
Published in:
American Journal of Hematology, 2016, v. 91, n. 11, p. E473, doi. 10.1002/ajh.24533
By:
- Merz, Maximilian;
- Hielscher, Thomas;
- Seckinger, Anja;
- Hose, Dirk;
- Mai, Elias K.;
- Raab, Marc S.;
- Goldschmidt, Hartmut;
- Jauch, Anna;
- Hillengass, Jens
Publication type:
Article
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1078725
By:
- John, Lukas;
- Miah, Kaya;
- Benner, Axel;
- Mai, Elias K.;
- Kriegsmann, Katharina;
- Hundemer, Michael;
- Kaudewitz, Dorothee;
- Müller-Tidow, Carsten;
- Jordan, Karin;
- Goldschmidt, Hartmut;
- Raab, Marc S.;
- Giesen, Nicola
Publication type:
Article
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.919278
By:
- Sandmann, Sarah;
- Karsch, Katharina;
- Bartel, Peter;
- Exeler, Rita;
- Brix, Tobias J.;
- Mai, Elias K.;
- Varghese, Julian;
- Lenz, Georg;
- Khandanpour, Cyrus
Publication type:
Article
Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myeloma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2293, doi. 10.1007/s00259-024-06668-z
By:
- Sachpekidis, Christos;
- Enqvist, Olof;
- Ulén, Johannes;
- Kopp-Schneider, Annette;
- Pan, Leyun;
- Mai, Elias K.;
- Hajiyianni, Marina;
- Merz, Maximilian;
- Raab, Marc S.;
- Jauch, Anna;
- Goldschmidt, Hartmut;
- Edenbrandt, Lars;
- Dimitrakopoulou-Strauss, Antonia
Publication type:
Article

Found: 22